D-0376-2021 Class II Terminated
FDA drug recall D-0376-2021 was initiated by Teva Pharmaceuticals USA on April 26, 2021 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated June 4, 2024). Affected quantity: 7,564/1 multiple dose vial per carton.
Recall Details
- Product Type
- Drugs
- Report Date
- May 26, 2021
- Initiation Date
- April 26, 2021
- Termination Date
- June 4, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7,564/1 multiple dose vial per carton
Product Description
Methylprednisolone Acetate Injectable Suspension USP, 40 mg/mL, 10 mL Multiple Dose Vial, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0703-0045-01
Reason for Recall
Lack of Assurance of Sterility
Distribution Pattern
Product was distributed nationwide.
Code Information
Lot # 31327989B, exp. date 04/2021